C-reactive protein in hypertensive disorders in pregnancy. (Q54540772)

31 May 2018

title

C-reactive protein in hypertensive disorders in pregnancy. (English)

1 reference

31 May 2018

author

Massimo Milani

5

1 reference

31 May 2018

Antonio Girolami

8

Antonio Girolami

1 reference

31 May 2018

Sara Fantinato

2

Sara Fantinato

1 reference

31 May 2018

Umberto Nicolini

7

Umberto Nicolini

1 reference

31 May 2018

Delia M Paternoster

1

Delia M Paternoster

1 reference

31 May 2018

author name string

Andrea Stella

3

1 reference

31 May 2018

Kimta Ngaradoumbe Nanhornguè

4

1 reference

31 May 2018

Mario Plebani

6

1 reference

31 May 2018

publication date

1 July 2006

1 reference

31 May 2018

Clinical and Applied Thrombosis-Hemostasis

published in

1 reference

31 May 2018

volume

12

1 reference

31 May 2018

issue

3

1 reference

31 May 2018

page(s)

330-337

1 reference

31 May 2018

Trends in maternal mortality in Australia: relevance in current practice

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1076029606291382

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029606291382

Preeclampsia: an excessive maternal inflammatory response to pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029606291382

Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029606291382

Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029606291382

Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029606291382

C-reactive protein (CRP) and pregnancy. An early indicator of chorioamnionitis. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029606291382

C-reactive protein during normal pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029606291382

C-reactive protein and the risk of developing hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029606291382

Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029606291382

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029606291382

Expectant management of severe preterm preeclampsia: is intrauterine growth restriction an indication for immediate delivery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029606291382

Better maternal outcomes are achieved with dexamethasone therapy for postpartum HELLP (hemolysis, elevated liver enzymes, and thrombocytopenia) syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029606291382

Time course of recovery and complications of HELLP syndrome with two different treatments: heparin or dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029606291382

Maternal and neonatal outcome in early- and late-onset pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029606291382

21 January 2018

Identifiers

DOI

10.1177/1076029606291382

1 reference

31 May 2018

PubMed ID

16959687

1 reference

31 May 2018